Kesios Therapeutics
London
About Kesios Therapeutics
Kesios Therapeutics Limited develops small molecule drugs for haematological malignancies, such as multiple myeloma and related indications. The company was incorporated in 2012 and is based in London, United Kingdom.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $31.4M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2016)
- Website: kesios.com
- Phone: +4402038189280
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kesios-therapeutics-3378800 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.